Work Area: Valuation

Latest content

WiLAN revenues plummet in Q3 on prior year but Micron deal excluded

Strategic review of the licensing business nears a year in motion with no news on potential divestment announced

10 November 2022

Drug royalty agreements can help Big Pharma overcome patent cliffs, says top dealmaker

Behzad Khosrowshahi, CEO of DRI Healthcare Trust, looks at recent deals the firm has done, explains what makes a transaction attractive and how to get one over the line

04 November 2022

IP finance, monetisation and much more take centre stage on Day One of IPBC Asia 2022

A broad range of subjects and talking points - including a plenary address from JPO Commissioner Koichi Hamano - kept the 400+ delegates engaged as the event got underway in Tokyo

01 November 2022

Embracing the future at Singapore’s IP office

In an exclusive interview, IPOS chief executive Rena Lee speaks about digital innovations and her ambitions for Singapore as an IP hub

27 October 2022

Draft US bill proposes federal SEP royalty court with global impact

Proposal seeks to resolve lengthy negotiations but stirs inventor community concerns

18 October 2022

Covid and economic fears spur rising IP monetisation trend

Companies in more industries and sectors are looking to raise capital using their intellectual property as collateral

28 September 2022

How flawed fintechs are running out of gas

Plummeting fintech stock prices are leading to an urgent re-evaluation of certain business models in the space. However, a closer look at intangible assets might hold the solution to this dilemma.

28 September 2022

Meet 2022’s IP Hall of Fame inductees

Following a selection process that ran between March and May, IAM announced that four new individuals had been chosen to join the IP Hall of Fame in 2022: Pravin Anand, Justice Stephen Breyer, Louis Foreman and James Malackowski. They were officially inducted at this year’s IPBC Global in June.

14 September 2022

The contribution patents make to enterprise value

No commonly used valuation methods are much help at putting a number on an entire portfolio unless there is a specific transaction on the horizon. Cipher’s Nigel Swycher and Steve Harris suggest an original methodology to fill this gap

03 August 2022

IP tax strategies come under fire from US senators

Legislators put pharma companies under the microscope and blame a law signed by President Trump in 2017 for patent-based payment mitigation

01 August 2022

Unlock unlimited access to all IAM content